Agomab Therapeutics is a series b startup. 3 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Agomab Therapeutics is a biopharmaceutical company translating the power of growth factors into novel medicines for fibrotic diseases.
Stage
series-b
Investors
3
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky